The subdivision of R-type drugs, which inhibit the reaction of p-nitrophenyl acetate with an active site (R site) located near the tyrosine-411 residue of human serum albumin (HSA), is proposed based on the results of kinetic and fluorometric studies. We found two kinds of R-type drugs with regard to the influence on the reaction rate of 3,5-dinitroaspirin (DA) at a site (U site) near the lysine-199 and tryptophan-214 (Trp-214) residues of HSA. One of them (R2-type drug, e.g., diazepam or medazepam) greatly accelerates the reaction of DA with HSA, and the other (R1-type drug, e.g., clofibric acid or octanoic acid) does not affect the reaction. The R2-type drug quenches the fluorescence originating from the Trp-214 residue in the U site of HSA, and the R1-type drug hardly influences this fluorescence. The acceleration of the reaction was considered to be due to the conformational change of the U site caused by binding of the R2-type drug to a part of the R site on HSA. Five benzodiazepines, 3 sulfonylureas, and 3 other drugs were classified into R1 -type and R2-type drugs.
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Pharm. Bull. 35 ( 2 ) The subdivision of R-type drugs, which inhibit the reaction of p-nitrophenyl acetate with an active site (R site) located near the tyrosine-411 residue of human serum albumin (HSA), is proposed based on the results of kinetic and fluorometric studies. We found two kinds of R-type drugs with regard to the influence on the reaction rate of 3,5-dinitroaspirin (DA) at a site (U site) near the lysine-199 and tryptophan-214 (Trp-214) residues of HSA. One of them (R2-type drug, e.g., diazepam or medazepam) greatly accelerates the reaction of DA with HSA, and the other (R1-type drug, e.g., clofibric acid or octanoic acid) does not affect the reaction. The R2-type drug quenches the fluorescence originating from the Trp-214 residue in the U site of HSA, and the R1-type drug hardly influences this fluorescence. The acceleration of the reaction was considered to be due to the conformational change of the U site caused by binding of the R2-type drug to a part of the R site on HSA. Five benzodiazepines, 3 sulfonylureas, and 3 other drugs were classified into R1 -type and R2-type drugs. In the previous papers2 -4) it was reported that human serum albumin (HSA) has esterase-like activity towards p-nitrophenyl acetate (NPA)2'3 ) and 2,4-dinitrophenyl diethyl phosphate (DDP),4) and the active site was found to be located close to the tyrosine-411 residue (named the R site3)) of the HSA amino acid sequence.5) Drugs which inhibit the reaction of NPA with HSA were referred to as R-type drugs.3) Since the R-type drugs were found to correspond to Sudlow's Site II drugs,6' 7) the R site is considered to be identical with Site II.
HSA has another reactive site for substituted aspirins (e.g., 3,5-dinitroaspirin, DA), and this site was found to be located near the lysine-199 residue (named the U site) of the sequence.8,9) The single tryptophan-214 (Trp-214) residue is also located in the U site and the binding of a drug to the U site decreased the fluorescence intensity of this residue.3'8) Drugs, which inhibit the reaction of DA with HSA and quench the fluorescence due to the Trp-214 residue, were referred to as U-type drugs. Because the U-type drugs correspond to Sudlow's Site I drugs, the U site appears to be identical with Site I.
Sjoholm et al.10)) and Fehske et al.11) reported that two drugs, diazepam and warfarin, function as specific markers for two specific drug-binding sites, i.e., the diazepam site and the warfarin site. Diazepam inhibited the reaction of NPA with HSA12'13) and it was, thus, considered to be an R-type drug.12) However, diazepam was, unlike other R-type drugs, found to cause acceleration of the reaction with DA and quenching of the fluorescence due to the Trp-214 residue of HSA. In this paper, we describe the basis for the subdivision of the R-type Effects of Drugs on the Reaction Rates of NPA and DDP with HSA Figure 1 shows the effects of four drugs on the reaction rate of NPA with HSA . In this figure, 1 ,;bs on the ordinate is the rate constant in the presence of drug and the concentrations with subscript 0 on the abscissa show the initial concentrations of drug and HSA . All these drugs inhibit the reaction of NPA with HSA. Figure 1 also illustrates the theoretical inhibition curves assuming different values of the dissociation constant (14 ,0 of the complex between the d rug and the R site of HSA. The curves were obtained by analog computer simulation of the reaction of NPA with HSA in the presence and absence of the drug . The details of the production of the inhibition curve are described elsewhere.23) From the inhibition curve giving the best fit to the experimental results, the dissociation constant (K, , R) was estimated, and the values are listed in Table I .
Some of the reciprocal values (1/KI ,R, M-1) of IC,,R (M) in Table I are similar to the binding constants found in the literature, and the others are significantly different ."' 24) The discrepancies of the parameters presumably arise from the differences of experimental procedures, such as equilibrium dialysis, ultrafiltration, and spectroscopy, and also from slight differences of the experimental conditions such as buffer components, ionic strength, and source of HSA. Figure 2 shows the effects of the drugs on the reaction rate of DDP with HSA. All these drugs inhibit the reaction, and the primary binding site for these drugs seems to be the R site.
Influence of Drug Binding on the U Site of HSA
The effects of the drugs on the reaction rate of DA with HSA are represented in Fig. 3 . There were two kinds of drugs in terms of the effects on the above reaction, one of which (named R2-type drugs, e.g., medazepam and diazepam) markedly accelerates the reaction and Figure   4 shows the fluorescence spectral change in the presence of the drug. Figure  5 illustrates 
